Commercial Nanopore Sequencer Remains 'Top Goal' for Electronic BioSciences after Nanopatch Launch | GenomeWeb

Electronic BioSciences is developing an electronic nanopore sequencing platform that promises high speed and low per-run costs.

Late last year, the company launched a version of its hardware platform, called Nanopatch, for electrophysiology measurements while continuing to optimize alpha-hemolysin nanopores for DNA sequencing.

Developing a commercial electronic nanopore sequencing system remains the firm's "top goal," according to Eric Ervin, EBS' vice president of research and development.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.